Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation: authors' reply ALIMENTARY PHARMACOLOGY & THERAPEUTICS Kim, W. R., Asrani, S. K. 2011; 33 (5): 616-617

View details for DOI 10.1111/j.1365-2036.2010.04571.x

View details for Web of Science ID 000286511100014